Business
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Acc...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n\n\n\n Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n CALGARY, AB\n \n\n ,\n \n\n July 9, 2025\n \n\n /CNW/ -\n \n Nanalysis Scientific Corp.\n \n (\"the Company\",\n \n TSXV: NSCI\n \n ,\n \n OTCQX: NSCIF\n \n ,\n \n FRA: 1N1\n \n ), a leader in portable NMR instruments and MRI technology for industrial and research applications announces the publication in the National Formulary of the first regulatory certified assay for benchtop NMR – the Molar Substitution Determination in Hydroxypropyl Betadex USP-NF/Ph.\n \n Euro (1804)\n \n .\n \n\n\n\n\n\n\n\n\n \"Currently Nanalysis sells primarily into industrial R&D labs and universities, but to more ubiquitously proliferate the use of benchtop NMR and drive higher sales growth, one of our strategic targets has been the development of gold standard methods for industrial quality control (QC) in pharma, polymers, chemical, food and other sectors. To accomplish this, NMR must become an accepted technique for regulatory authorities such as USP. Until recently, this has not happened because traditional large superconducting high-field NMR magnet technology has been excluded from industrial QC because of its complexity, cost, and safety issues which has rendered it economically unviable,\" said Dr.\n \n Susanne D. Riegel\n \n , Nanalysis VP Marketing & NMR Product Manager. \"Having certified regulatory methods that specifically use 60 MHz benchtop NMR for approved assays is an initial and important step for larger scale global deployment of benchtop NMR for industrial QC.\"\n \n\n Nanalysis has been working with thought leaders for many years from within industry and regulatory bodies to identify key assays for polymers and pharmaceuticals that would benefit from modernization, and possibly digitalization. With a global billion-dollar market, hydroxypropyl betadex, was a clear, early target...